Novo Nordisk Pharma introduced its Mallya Smart Sensor at the Digital Healthcare Forum of Korea Digital Future Innovation Exhibition 2023, the Danish pharmaceutical company said Monday.
The popularity of Novo Nordisk's weight-loss drug Wegovy has made the Danish company the most valuable in Europe; Korean pharmas are now seeking a share of the lifestyle drugs market.
As the world grapples with the obesity epidemic, pharmaceutical companies are increasingly tapping into the fast-burgeoning market for weight-loss drugs.
Korea JoongAng Daily Sitemap